Recurrence patterns after postoperative radiotherapy for squamous cell carcinoma of the pharynx and larynx

被引:17
|
作者
Iizuka, Yusuke [1 ]
Yoshimura, Michio [1 ]
Inokuchi, Haruo [1 ]
Matsuo, Yukinori [1 ]
Nakamura, Akira [1 ]
Mizowaki, Takashi [1 ]
Hirano, Shigeru [2 ]
Kitamura, Morimasa [2 ]
Tateya, Ichiro [2 ]
Hiraoka, Masahiro [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Kyoto, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan
关键词
Metastasis; postoperative radiotherapy; prognostic factors; INTENSITY-MODULATED RADIOTHERAPY; LOCALLY ADVANCED HEAD; NECK-CANCER; CHEMOTHERAPY; THERAPY;
D O I
10.3109/00016489.2014.949848
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Conclusions: Distant metastasis was a major pattern of recurrence after postoperative radiotherapy (PORT) for squamous cell carcinoma (SCC) of the oropharynx, hypopharynx, and larynx. PORT provided good loco-regional control, with tolerable toxicities. Advanced pT and pN were unfavorable prognostic factors. Objective: To determine the clinical outcomes, and the patterns and risk factors for recurrence of SCCs of the oropharynx, hypopharynx, and larynx treated with surgery and PORT. Methods: We retrospectively reviewed 84 patients who received PORT after definitive surgery for SCC of the oropharynx, hypopharynx, or larynx between 2000 and 2010. The primary sites were the oropharynx in 25 patients, hypopharynx in 47 patients, and larynx in 12 patients. Results: The 3-year overall survival (OS), progression-free survival (PFS), and loco-regional control (LRC) rates were 64.9%, 56.7%, and 92.1%, respectively. Recurrences were observed in 27 patients: 6 patients had loco-regional recurrence and 23 patients developed distant metastasis. On multivariate analysis, pT4 and pN2c-N3 displayed significantly worse effects on OS (p = 0.02 and p < 0.01, respectively) and PFS (p = 0.02 and p < 0.001, respectively). In the acute phase, 12 patients experienced grade 3 or 4 toxicities. There were no grade 5 toxicities. Late grade 3 toxicity developed in six patients and no grade 4 or 5 toxicities were observed.
引用
收藏
页码:96 / 102
页数:7
相关论文
共 50 条
  • [21] Oncologic outcome with versus without target volume compartmentalization in postoperative radiotherapy for oral cavity squamous cell carcinoma
    Riggenbach, Elena
    Waser, Manuel
    Mueller, Simon A.
    Aebersold, Daniel M.
    Giger, Roland
    Elicin, Olgun
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [22] Gamma tubulin: A promising indicator of recurrence in squamous cell carcinoma of the larynx
    Syed, Mohammed Lqbal
    Syed, Sheeba
    Minty, Fay
    Harrower, Steven
    Singh, Jatinder
    Chin, Andy
    McLellan, Douglas R.
    Parkinson, Eric K.
    Clark, Louise J.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2009, 140 (04) : 498 - 504
  • [23] Radiotherapy in Larynx Squamous Cell Carcinoma is not Associated with an Increased Diagnosis of Second Primary Tumours
    Farhadieh, R. D.
    Rees, C. G. G.
    Yang, J. L.
    Salardini, A.
    Russell, P.
    Smee, R.
    CLINICAL ONCOLOGY, 2009, 21 (04) : 315 - 319
  • [24] Postoperative Radiotherapy and Survival in Oral Cavity Squamous Cell Carcinoma With Mandibulectomy
    Harley, Randall J.
    Iheagwara, Uzoma K.
    Faraj, Farhoud
    Sridharan, Shaum
    Kubik, Mark W.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2024, 150 (03) : 233 - 239
  • [25] Distant metastases in squamous cell carcinoma of the pharynx and larynx: a population-based DAHANCA study
    Kjems, Julie
    Zukauskaite, Ruta
    Johansen, Jorgen
    Eriksen, Jesper Grau
    Lassen, Pernille
    Andersen, Elo
    Andersen, Maria
    Farhadi, Mohammad
    Overgaard, Jens
    Vogelius, Ivan R.
    Friborg, Jeppe
    ACTA ONCOLOGICA, 2021, 60 (11) : 1472 - 1480
  • [26] Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: Patterns of failure
    Chan, Andrew K.
    Huang, Shao Hui
    Le, Lisa W.
    Yu, Eugene
    Dawson, Laura A.
    Kim, John J.
    Cho, B. C. John
    Bayley, Andrew J.
    Ringash, Jolie
    Goldstein, David
    Chan, Kelvin
    Waldron, John
    O'Sullivan, Brian
    Cummings, Bernard
    Hope, Andrew J.
    ORAL ONCOLOGY, 2013, 49 (03) : 255 - 260
  • [27] Platin-Based Exclusive Chemotherapy for Selected Patients With Squamous Cell Carcinoma of the Larynx and Pharynx
    Holsinger, F. Christopher
    Lin, Heather Y.
    Bassot, Vincent
    Laccourreye, Ollivier
    CANCER, 2009, 115 (17) : 3909 - 3918
  • [28] Retrospective study of treatment outcomes after postoperative chemoradiotherapy in Japanese oral squamous cell carcinoma patients with risk factors of recurrence
    Hasegawa, Takumi
    Yanamoto, Souichi
    Otsuru, Mitsunobu
    Yamada, Shin-ichi
    Minamikawa, Tsutomu
    Shigeta, Takashi
    Naruse, Tomofumi
    Suzuki, Takatsugu
    Sasaki, Masashi
    Ota, Yoshihide
    Umeda, Masahiro
    Komori, Takahide
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2017, 123 (05): : 524 - 530
  • [29] Postoperative radiotherapy for patients with oral squamous cell carcinoma with intermediate risk of recurrence: A case match study
    Barry, Conor P.
    Wong, Daniel
    Clark, Jonathan R.
    Shaw, Richard J.
    Gupta, Ruta
    Magennis, Patrick
    Triantafyllou, Asterios
    Gao, Kan
    Brown, James S.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (07): : 1399 - 1404
  • [30] INTENSITY-MODULATED RADIOTHERAPY FOR ORAL CAVITY SQUAMOUS CELL CARCINOMA: PATTERNS OF FAILURE AND PREDICTORS OF LOCAL CONTROL
    Daly, Megan E.
    Quynh-Thu Le
    Kozak, Margaret M.
    Maxim, Peter G.
    Murphy, James D.
    Hsu, Annie
    Loo, Billy W., Jr.
    Kaplan, Michael J.
    Fischbein, Nancy J.
    Chang, Daniel T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (05): : 1412 - 1422